Lys05
CAS No. 1391426-24-6
Lys05( Lys-05 | Lys 05 | Lys01 trihydrochloride | PS-1001 )
Catalog No. M11622 CAS No. 1391426-24-6
Lys05 (Lys01 trihydrochloride, PS-1001) is the water-soluble salt of Lys01, is a 10-fold more potent lysosomal autophagy inhibitor than hydroxychloroquine (HCQ); shows IC50 values of 3.6, 3.8, 6 and 7.9 uM for 1205Lu, c8161, LN229 and HT-29 cell line in the MTT assay.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 211 | In Stock |
|
| 50MG | 346 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1070 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLys05
-
NoteResearch use only, not for human use.
-
Brief DescriptionLys05 (Lys01 trihydrochloride, PS-1001) is the water-soluble salt of Lys01, is a 10-fold more potent lysosomal autophagy inhibitor than hydroxychloroquine (HCQ); shows IC50 values of 3.6, 3.8, 6 and 7.9 uM for 1205Lu, c8161, LN229 and HT-29 cell line in the MTT assay.
-
DescriptionLys05 (Lys01 trihydrochloride, PS-1001) is the water-soluble salt of Lys01, is a 10-fold more potent lysosomal autophagy inhibitor than hydroxychloroquine (HCQ); shows IC50 values of 3.6, 3.8, 6 and 7.9 uM for 1205Lu, c8161, LN229 and HT-29 cell line in the MTT assay; more potently accumulates within and deacidifies the lysosome, resulting in impaired autophagy and tumor growth; enhances sunitinib-mediated suppression of clear cell ovarian carcinoma (CCOC) cell viability.
-
In VitroLys01, is a 10-fold more potent autophagy inhibitor than HCQ. Compared with HCQ, Lys05, a water-soluble salt of Lys01, more potently accumulates within and deacidifies the lysosome. Lys01 and Lys05 produce equivalent dose-dependent increases in the LC3II/LC3I ratio, accumulation of the autophagy cargo protein p62, and identical IC50 values in the MTT assay.
-
In VivoWith this high-dose, short-term treatment, no mice die, but after 2 d of dosing, mice treated with Lys05 76 mg/kg i.p. are observed to have arched backs and lethargy. Morphologically, EM show that cells with intact nuclear and cytoplasmic membranes contain large AVs in Lys05-treated tumors. Tumor growth is significantly impaired in Lys05-treated tumors compared with controls. Lys05 treatment results in a 53% reduction in the average daily tumor growth rate compared with vehicle-treated controls. A significant three- and six-fold accumulation of AV is observed at the end of 14 d of treatment in HCQ- and Lys05-treated tumors, respectively, compared with control-treated tumors.
-
SynonymsLys-05 | Lys 05 | Lys01 trihydrochloride | PS-1001
-
PathwayAutophagy
-
TargetAutophagy
-
Recptorlysosomalautophagy(1205Lu)|lysosomalautophagy(c8161)|lysosomalautophagy(HT-29)|lysosomalautophagy(LN229)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1391426-24-6
-
Formula Weight549.75
-
Molecular FormulaC23H26Cl5N5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 6.4 mg/mL, Need Ultrasonic; Water: 3 mg/mL (5.5 mM); Ethanol: <1 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESCN(CCNC1=CC=NC2=CC(Cl)=CC=C12)CCNC3=CC=NC4=CC(Cl)=CC=C34.[H]Cl.[H]Cl.[H]Cl
-
Chemical NameN2-(7-Chloro-4-quinolinyl)-N1-[2-[(7-chloro-4-quinolinyl)amino]ethyl]-N1-methyl-1,2-ethanediamine trihydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. McAfee Q, et al. Proc Natl Acad Sci U S A. 2012 May 22;109(21):8253-8.
2. Amaravadi RK, et al. Autophagy. 2012 Sep;8(9):1383-4.
3. DeVorkin L, et al. Mol Cancer Res. 2017 Mar;15(3):250-258.
4. Ndoye A, et al. Cancer Res. 2017 Nov 1;77(21):5873-5885.
molnova catalog
related products
-
QN523?
QN523 represents a novel scaffold with drug-like properties, showing potent in vitro cytotoxicity in a panel of 12 cancer cell lines.
-
SJFα
SJFα (SJF alpha) is a PROTAC formed by an E3 ubiquitin ligase-conjugated protein hydrolysis regulator that degrades p38α and p38δ and can be used in cancer research.
-
GC7 Sulfate
GC7 Sulfate is a potent inhibitor of deoxyhypusine synthase (DHS). Eukaryotic translation initiation factor 5A2 (eIF5A2) is the only known substrate for DHS, so GC7 inhibits the activation of eIF5A2 by inhibiting DHS activity.
Cart
sales@molnova.com